Provention Bio

About Provention Bio

Provention Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapeutics aimed at intercepting and preventing immune-mediated diseases. The company operates in the healthcare sector, specifically targeting autoimmune and inflammatory diseases. Provention Bio serves patients who suffer from chronic conditions such as Type 1 Diabetes (T1D), Crohn's Disease, and Systemic Lupus Erythematosus. The company's business model revolves around the research, development, and commercialization of its therapeutic candidates. Revenue is generated primarily through partnerships, licensing agreements, and eventual product sales upon regulatory approval. Provention Bio aims to reduce the high morbidity, mortality, and escalating costs associated with these diseases by intervening before they begin, reappear, or progress. The company is dedicated to transforming treatment paradigms into interception and prevention strategies, thereby improving the quality of life for millions of patients worldwide.